Innovation in Motion: GRIN2B Patent Marks Key Advancement

Innovation in Motion: GRIN2B Patent Marks Key Advancement Professor Shai Berlin, a lead scientist with the 2BCured research team, announced the issuance of a patent for a novel gene therapy aimed at treating GRIN2B-Related Neurodevelopmental Disorder. The patent involves use of a recombinant adeno-associated virus (AAV) vector capable of delivering a full-length, healthy GRIN2B gene […]